The a2 Milk Company Limited logo

Ongoing Disclosure Notices – Multiple

Insider Disclosure1 March 2018ATMConsumer Staples

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

The a2 Milk Company Limited

Date this disclosure made:

01/03/2018

Date of last disclosure:

29/08/2017

Director or senior manager giving disclosure

Full name(s):

John Scott WOTHERSPOON

Name of listed issuer:

The a2 Milk Company Limited

Name of related body corporate (if applicable):

Position held in listed issuer:

Chief Executive UK and Europe

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

(1) Unlisted options to subscribe for Ordinary

Shares in the Company; (2)-(5) Ordinary Shares

Nature of the affected relevant interest(s):

(1)-(5) Legal and beneficial owner

For that relevant interest-

Number held in class before acquisition or disposal:

(1) 3,200,998 Options; (2)-(5) 800,000 Ordinary

Shares

Number held in class after acquisition or disposal:

(1) 2,400,998 Options; (2)-(5) 400,000 Ordinary

Shares

Current registered holder(s):

John Scott Wotherspoon

Registered holder(s) once transfers are registered:

(1) John Scott Wotherspoon; (2)-(5) Unknown

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial products

(if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable under the

derivative or the value of the derivative is affected by the value of the underlying financial

products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant interest

in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates:

5

Details of transactions requiring disclosure-

Date of transaction:

(1)-(2) 22/02/2018; (3) 23/03/2018; (4)-(5)

26/02/2018

Nature of transaction:

(1) Issue of 800,000 Ordinary Shares following

exercise of 800,000 Options; (2) On market sale

of 250,000 Ordinary Shares through broker

facilities; (3) On market sale of 1,160 Ordinary

Shares through broker facilities; (4)-(5) On market

sale of 148,840 Ordinary Shares (in aggregate)

through broker facilities

Name of any other party or parties to the transaction (if known):

Unknown

The consideration, expressed in New Zealand dollars, paid or received for the acquisition or
disposal. If the consideration was not in cash and cannot be readily by converted into a cash

value, describe the consideration:

(1) $504,000 paid to exercise the Options; (2)

$3,200,000 receivable for on market sale of

Ordinary Shares through broker facilities; (3)

$14,906 receivable for on market sale of Ordinary

Shares through broker facilities; (4)-(5)

$1,897,392.10 receivable (in aggregate) for on

market sale of Ordinary Shares through broker

facilities

Number of financial products to which the transaction related:

(1) 800,000 Options; (2) 250,000 Ordinary

Shares; (3) 1,160 Ordinary Shares; (4)-(5)

148,840 Ordinary Shares (in aggregate)

If the issuer has a financial products trading policy that prohibits directors or senior managers

from trading during any period without written clearance (a closed period) include the following

details—

Whether relevant interests were acquired or disposed of during a closed period:

Nil

Whether prior written clearance was provided to allow the acquisition or disposal to proceed

during the closed period:

N/A

Date of the prior written clearance (if any):

N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial products

(if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable under the

derivative or the value of the derivative is affected by the value of the underlying financial

products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant interest

in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is

correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

Name and title of authorised person:

Notes

Use this form to disclose all the acquisitions and disposals by a director or senior manager of a

listed issuer, or of a related body corporate, or in specified derivatives. The disclosure must be

made within—

(a) 20 working days after the first acquisition or disposal disclosed in this notice if the

acquisitions or disposals are of a kind referred to in section 297(2)(a) of the Financial Markets

Conduct Act 2013; or

(b) in any other case, 5 trading days after the first acquisition or disposal disclosed in

this notice.

28 February 2018

---

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 1

Rule 3.19A.2

Appendix 3Y


Change of Director’s Interest Notice


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11


Name of entity The a2 Milk Company Limited

ABN 97 769 415 292


We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for

the director for the purposes of section 205G of the Corporations Act.


Name of Director

Geoffrey Babidge

Date of last notice

29 August 2017


Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust


Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Direct or indirect interest

Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the

relevant interest.

Geoffrey Babidge’s relevant interest is held on

trust by GCAA Investments Pty Ltd.

Date of change

For (1), (2) and (3) 22 February 2018;

For (4) 23 February 2018;

For (5) 26 February 2018.

No. of securities held prior to change

4,000,000 partly paid ordinary shares.

Class

Fully paid ordinary shares and partly paid

ordinary shares.

Number acquired

2,000,000 fully paid ordinary shares.

Number disposed

1. 2,000,000 partly paid ordinary shares (by

virtue of payment up of those ordinary

shares in full) – the resultant 2,000,000

fully paid ordinary shares are those

referred to in (2) to (5) immediately

below.

2. 500,000 fully paid ordinary shares.

3. 500,000 fully paid ordinary shares.

4. 300,000 fully paid ordinary shares.

5. 200,000 fully paid ordinary shares.

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


Appendix 3Y Page 2 01/01/2011

Value/Consideration

Note: If consideration is non-cash, provide details and estimated

valuation

1. NZ$ 1,267,200 paid up on the partly paid

ordinary shares.

2. NZ$6,800,000 (sale price for on market

sale of 500,000 ordinary shares).

3. NZ$6,477,676 (sale price for on market

sale of 500,000 ordinary shares).

4. NZ$3,888,690 (sale price for on market

sale of 300,000 ordinary shares).

5. NZ$2,563,100 (sale price for on market sale

of 200,000 ordinary shares).

No. of securities held after change

1. 2,000,000 partly paid ordinary shares.

2. 500,000 fully paid ordinary shares.

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue

of securities under dividend reinvestment plan, participation in buy-back

1. Full payment of 2,000,000 partly paid

ordinary shares.

2. Sale of 500,000 ordinary shares on market

through broker facilities.

3. Sale of 500,000 ordinary shares on market

through broker facilities.

4. Sale of 300,000 ordinary shares on market

through broker facilities.

5. Sale of 200,000 ordinary shares on market

through broker facilities.

The share transactions are to maintain a

balanced overall investment portfolio. Mr

Babidge is to retire from his CEO role in July

2018.

As noted elsewhere on this form, Mr Babidge

continues to hold a relevant interest in

500,000 fully paid ordinary shares and

2,000,000 partly paid ordinary shares.


Part 2 – Change of director’s interests in contracts


Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Detail of contract

n/a

Nature of interest

n/a

Name of registered holder

(if issued securities)

n/a

Date of change

n/a

No. and class of securities to which

interest related prior to change

Note: Details are only required for a contract in

relation to which the interest has changed

n/a

Interest acquired

n/a

Interest disposed

n/a

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 3

Value/Consideration

Note: If consideration is non-cash, provide details

and an estimated valuation

n/a

Interest after change

n/a


Part 3 –

+

Closed period


Were the interests in the securities or contracts detailed

above traded during a

+

closed period where prior written

clearance was required?

No

If so, was prior written clearance provided to allow the trade

to proceed during this period?

n/a

If prior written clearance was provided, on what date was

this provided?

n/a

---

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 1

Rule 3.19A.2

Appendix 3Y


Change of Director’s Interest Notice


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11


Name of entity The a2 Milk Company Limited

ABN 97 769 415 292


We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for

the director for the purposes of section 205G of the Corporations Act.


Name of Director

Peter Hinton

Date of last notice

29 August 2017


Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust


Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Direct or indirect interest

Direct

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the

relevant interest.

N/A

Date of change

For (1) and (2) 23 February 2019;

For (3), (4), (5) and (6) 26 February 2018;

For (7) 27 February 2018

No. of securities held prior to change

775,000

Class

Fully paid ordinary shares

Number acquired

Nil

Number disposed

1. 75,000 fully paid ordinary shares.

2. 5,000 fully paid ordinary shares.

3. 15,000 fully paid ordinary shares.

4. 3,170 fully paid ordinary shares.

5. 1,000 fully paid ordinary shares.

6. 830 fully paid ordinary shares.

7. 25,000 fully paid ordinary shares.

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


Appendix 3Y Page 2 01/01/2011

Value/Consideration

Note: If consideration is non-cash, provide details and estimated

valuation

1. NZ$972,742.50 sale price for 75,000

ordinary shares.

2. NZ$63,950 sale price for 5,000 ordinary

shares.

3. NZ$192,000 sale price for 15,000 ordinary

shares.

4. NZ$40,734.50 sale price for 3,170 ordinary

shares.

5. NZ$12,870 sale price for 1,000 ordinary

shares.

6. NZ$10,707 sale price for 830 ordinary

shares.

7. NZ$329,000 sale price for 25,000 ordinary

shares.

No. of securities held after change

650,000 fully paid ordinary shares

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue

of securities under dividend reinvestment plan, participation in buy-back

1. Sale of 75,000 ordinary shares on market

through broker facilities.

2. Sale of 5,000 ordinary shares on market

through broker facilities.

3. Sale of 15,000 ordinary shares on market

through broker facilities.

4. Sale of 3,170 ordinary shares on market

through broker facilities.

5. Sale of 1,000 ordinary shares on market

through broker facilities.

6. Sale of 830 ordinary shares on market

through broker facilities.

7. Sale of 25,000 ordinary shares on market

through broker facilities.


Part 2 – Change of director’s interests in contracts


Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Detail of contract

n/a

Nature of interest

n/a

Name of registered holder

(if issued securities)

n/a

Date of change

n/a

No. and class of securities to which

interest related prior to change

Note: Details are only required for a contract in

relation to which the interest has changed

n/a

Interest acquired

n/a

Interest disposed

n/a

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 3

Value/Consideration

Note: If consideration is non-cash, provide details

and an estimated valuation

n/a

Interest after change

n/a


Part 3 –

+

Closed period


Were the interests in the securities or contracts detailed

above traded during a

+

closed period where prior written

clearance was required?

No

If so, was prior written clearance provided to allow the trade

to proceed during this period?

n/a

If prior written clearance was provided, on what date was

this provided?

n/a

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • NZX — NZX Limited: D&O Ongoing Disclosure – Jon Macdonald
    2017-12-21

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 22-Dec-17 Date of last disclosure: 4-Sep-1…”

  • NZX — NZX Limited: D&O Ongoing Disclosures – Multiple
    2018-04-04

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made:4-Apr-18 Date of last disclosure: 22-May-17 D…”

  • OCA — Oceania Healthcare Limited: D&O Ongoing Disclosures – Multiple
    2018-01-25

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and ASX Name of listed issuer: Oceania Healthcare Limited Date this disclosure made: 26-Jan-18 Date of last di…”